To assess the mutation of HIF1α in pan-cancer, we conducted an in-depth study using the cBioPortal database and found that HIF1α was altered in 5% (132/2583) of pan-cancer patients (Figure 5(a)). The gene discussed is HIF1A; the disease is cancer.